
Uppsala Reports editor
@UMCGlobalSafety
Dili, Timor Leste. Photo: Tanushree Rao on Unsplash
Timor Leste becomes the latest associate member of WHO Programme for International Drug Monitoring.
Flag of Timor Leste
In May 2019, Timor Leste joined the WHO Programme for International Drug Monitoring as an associate member. Timor Leste, which first gained independence and became a United Nations member state in 2002, is now one of 30 associate members alongside the 136 full members of the WHO programme.
Read more:
In January 2018, the national centre of Azerbaijan became the 130th full member of the WHO Programme for International Drug Monitoring - and there is much progress to report.
WHO programme / 23 June 2022
Luxembourg joined the WHO Programme for International Drug Monitoring in 2020, and being part of the network has already supported the growth of the pharmacovigilance department.
WHO programme / 04 May 2022
The National Health Regulatory Authority in Nicaragua is working across all sectors to improve medicines safety in their country.
WHO programme / 02 November 2022